Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search

Comprehensive scientific and clinical solutions to address the critical challenge of drug resistance by prioritization in drug design and therapeutic strategies.

 

Our Mission 

Page Menu
  • Medicines Designed to Last

    celia-schiffer-video-thumbnail.jpg
  • Uncovering Pathways to Resistance in cancer

    daniel-bolon-video-thumbnail.jpg
  • Chemo Chainsaw

    sharon-cantor-video-thumbnail.jpg
  • Overcoming Therapeutic Resistance in Pancreatic Cancer

    brian-lewis-video-thumbnail.jpg
  • Designed Biologics as Antivirals to avoid Drug Resistance

    yang-wang-video-thumbnail.jpg
  • Newest Drugs for the Oldest Parasites

    raffi-aroian-video-thumbnail.jpg
  • Thwarting Antibiotic Resistance in Psuedonomas Aerginosa

    pukkila-worley-video-thumbnail.jpg
  • Using Structural Biology to Tackle Antibiotic Resistance

    andrei-korostelev-video-thumbnail.jpg
  • Modifying Bacterial Behavior to Avoid Antibiotic Resistance

    elizabeth-shank-video-thumbnail.jpg
  • How to Discover New Antibiotics by Getting Bacteria to “Talk” to Each Other

    elizabeth-shank-video2-thumbnail.jpg
  • How I Stopped Worrying and Learned to Love the Microbiome

    robert-finberg-video-thumbnail.jpg
  • Bacteria Infection of Cancer Tumors – The Hidden Passengers we Ignored for too Long

    amir-mitchell-video-thumbnail.jpg
  • Preventing Antibiotic Resistance by Blocking Evolution

    brian-kelch-video-thumbnail.jpg

Latest News

Getting Results…
  • Communicating science: Daniel Bolon explains drug resistance in cancer cells
    Media, Research News

    Communicating science: Daniel Bolon explains drug resistance in cancer cells

    Daniel Bolon, PhD, said he lost his grandfather to cancer as a child, and the loss inspired him to pursue research into the disease. He studies drug resistance in cancer.

    Read more
  • Celia Schiffer named chair of Department of Biochemistry & Molecular Biotechnology
    Research News

    Celia Schiffer named chair of Department of Biochemistry & Molecular Biotechnology

    Celia A. Schiffer, PhD, has been named chair of the Department of Biochemistry & Molecular Biotechnology, newly renamed to reflect the expanded role of cutting-edge technologies as well as the science of pharmacology in bringing a molecular perspective to problems in biology and medicine.

    Read more
  • Dean Lane to 57 new doctoral candidates: Collaboration key to science
    Education News

    Dean Lane to 57 new doctoral candidates: Collaboration key to science

    The Morningside Graduate School of Biomedical Sciences at UMass Chan Medical School honored 57 new doctoral candidates during the Qualifying Exam Recognition Ceremony on Tuesday, Sept. 14.

    Read more
  • Communicating science: Institute for Drug Resistance video series elevates awareness, understanding
    Media, Research News

    Communicating science: Institute for Drug Resistance video series elevates awareness, understanding

    In a new video series, UMass Medical School scientists explain their research to address the global health challenge of drug resistance. In the first video of the series, Medicines Designed to Last, Celia Schiffer, PhD, sets the stage with a straightforward overview of drug resistance.

    Read more
  • UMass Medical School receives $2.8 million grant for advanced cryo-EM microscope
    Research News

    UMass Medical School receives $2.8 million grant for advanced cryo-EM microscope

    Roger Davis, PhD, FRS, and the Cryo-EM Core facility at UMass Medical School have received $2.8 million from The Massachusetts Life Sciences Center to purchase an advanced Glacios cryo-electron microscope from Thermo Fisher Scientific.

    Read more
  • Immunology and microbiology PhD candidate aims to use her voice in science policy career
    Education News, Media

    Immunology and microbiology PhD candidate aims to use her voice in science policy career

    PhD candidate Sarah Cleveland’s mission is to ensure that diverse voices are represented and heard. Cleveland, who studies mechanisms of T cell tolerance, wants to pursue a career in science policy after earning her degree.

    Read more
  • Cantor lab rethinks how common chemotherapy drug used in breast and ovarian cancer works
    Research News

    Cantor lab rethinks how common chemotherapy drug used in breast and ovarian cancer works

    Research from the lab of Sharon Cantor, PhD, provides a new understanding of a PARP inhibitor, a chemotherapy drug commonly used against breast and ovarian cancer.

    Read more
  • For GSBS class speaker Sumeet Nayak science brings hope
    Education News, Media

    For GSBS class speaker Sumeet Nayak science brings hope

    Sumeet Nayak’s research in the lab of Sharon B. Cantor, PhD, has led to a renewed understanding of how cancer develops and has opened up avenues to effectively advance anti-cancer therapies.

    Read more
  • Roger Davis elected to American Academy of Arts & Sciences
    Research News

    Roger Davis elected to American Academy of Arts & Sciences

    Roger J. Davis, PhD, FRS, has been elected a member of the American Academy of Arts & Sciences in recognition of his research on stress signaling pathways that are connected to a range of diseases, such as arthritis, cancer, stroke, heart disease and diabetes.

    Read more
  • David McManus and Brian Lewis named to endowed chairs
    Community News

    David McManus and Brian Lewis named to endowed chairs

    The University of Massachusetts Board of Trustees approved two “accomplished and visionary” University of Massachusetts faculty as endowed chairs at its April meeting.

    Read more
Showing 1-10 of 32 items
of 4